AJ
DNA icon

Ashburton (Jersey)’s Ginkgo Bioworks DNA Stock Holding History

Ashburton (Jersey)’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1K Hold
125
– – ﹤0.01% 51
2024
Q3 		$1K Buy
+125
New +$1.25K ﹤0.01% 47
2023
Q4 		$9K Hold
125
– – ﹤0.01% 48
2023
Q3 		$9K Hold
125
– – ﹤0.01% 49
2023
Q2 		$9K Buy
+125
New +$7.4K ﹤0.01% 49

Other funds holding DNA

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Ashburton (Jersey)'s DNA Position: Q4 2024 in Review

Ashburton (Jersey) held its Ginkgo Bioworks (DNA) position steady in Q4 2024 at 125 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #51.

Ashburton (Jersey) first reported a position in DNA in Q2 2023 and has held it in 5 quarters since. The position peaked at $9K in Q4 2023. 166 funds tracked by Wall St. Rank hold DNA as of Q4 2024.

  • Ashburton (Jersey) held 125 shares of Ginkgo Bioworks worth $1K as of Q4 2024.
  • Ashburton (Jersey) left its Ginkgo Bioworks share count unchanged in Q4 2024.
  • Ginkgo Bioworks made up ﹤0.01% of Ashburton (Jersey)'s portfolio in Q4 2024, its #51 holding.
  • Ashburton (Jersey) first reported a position in Ginkgo Bioworks in Q2 2023 and has held it in 5 quarters since.
  • Ashburton (Jersey)'s Ginkgo Bioworks position peaked at $9K in Q4 2023.
  • 166 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2024.

Based on Ashburton (Jersey)'s 13F filing for Q4 2024, filed 13 Feb 2025.